- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for mhp
MP Stock Earnings: MP Materials Misses EPS, Beats Revenue for Q1 2024
MP stock results show that MP Materials missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Thursday Apple Rumors: They Only Want iPad
Hewlett-Packard shareholders should be nervous about Q2 earnings — the TouchPad can’t get out from underneath the shadow of the iPad.
RHP Stock Earnings: Ryman Hospitality Props Misses EPS, Misses Revenue for Q1 2024
RHP stock results show that Ryman Hospitality Props missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
BIDU Stock Pops as Baidu, Tesla Team Up on Self-Driving Deal
BIDU stock is trending on Monday after Baidu announced a map-sharing deal with Tesla for self-driving vehicle technology.
Earnings Momentum Keeps MLP & Strategic Equity Fund (MTP) a Sell
Currently, MLP & Strategic Equity Fund (NASDAQ:MTP) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier’s investing methodology. MTP has maintained…
MLP & Strategic Equity Fund (MTP) a Sell on Flopping Earnings Visibility
MLP & Strategic Equity Fund (NASDAQ:MTP) is classified as a component of the 349 company Biotechnology GICS industry group, which is a segment of the…
Analytics for Industry Group Rank Keep MLP & Strategic Equity Fund (MTP) a Sell
MLP & Strategic Equity Fund (NASDAQ:MTP) is a $40.9 billion in market value component of the Biotechnology GICS industry group where the current Portfolio Grader…
MLP & Strategic Equity Fund (MTP) a Sell on Adverse Earnings Growth
The current recommendation of Sell for MLP & Strategic Equity Fund (NASDAQ:MTP) is the result of using the system for investing of Louis Navellier and…
Analytics for Quant Score Make MLP & Strategic Equity Fund (MTP) a Sell
The current recommendation of Sell for MLP & Strategic Equity Fund (NASDAQ:MTP) is computed using the methods for investing of Louis Navellier and his Portfolio…
Earnings Visibility Make MLP & Strategic Equity Fund (MTP) a Sell
Portfolio Grader currently ranks MLP & Strategic Equity Fund (NASDAQ:MTP) a Sell. The methods for fundamental and quantitative metrics used in this analytical tool, developed…
MLP & Strategic Equity Fund (MTP) Sell Recommendation Retained
Portfolio Grader currently ranks MLP & Strategic Equity Fund (NASDAQ:MTP) a Sell. Using Louis Navellier’s investing methodology, this analytical tool researches stocks by employing proprietary…
MLP & Strategic Equity Fund (MTP) a Sell on Flagging Sales Growth
MLP & Strategic Equity Fund (NASDAQ:MTP) ranks in the top 10% of its industry group, Biotechnology, and in the top 10% of its sector group,…
Earnings Visibility Keeps MLP & Strategic Equity Fund (MTP) a Sell
MLP & Strategic Equity Fund (NASDAQ:MTP) is a member of the 345 company Biotechnology GICS industry group, which is part of the 782 company GICS…
Adverse Earnings Growth Keep MLP & Strategic Equity Fund (MTP) a Sell
As one of the 785 companies in the GICS Health Care sector MLP & Strategic Equity Fund (NASDAQ:MTP) is a member of the 349 company…
10 – 10 of 240 results